Disc Medicine, Inc.
Price Action
Technical Summary
CONSOLIDATINGDisc Medicine, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 54), indicating performance broadly in line with the market. Earnings contraction of 62% provides fundamental context to the price action. Investors should exercise caution due to high volatility (51% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $69.89 | +6.59% | ABOVE |
| 50 SMA | $68.92 | +8.09% | ABOVE |
| 100 SMA | $67.14 | +10.96% | ABOVE |
| 150 SMA | $72.64 | +2.56% | ABOVE |
| 200 SMA | $73.49 | +1.37% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IRON in an uptrend right now?
IRON has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is IRON overbought or oversold?
IRON's RSI (14) is 66. The stock is in neutral territory, neither overbought nor oversold.
Is IRON outperforming the market?
IRON has a Relative Strength (RS) Rating of 54 out of 99. IRON is performing about average compared to the market.
Where is IRON in its 52-week range?
IRON is trading at $74.50, which is 75% of its 52-week high ($99.50) and 58% above its 52-week low ($40.00).
How volatile is IRON?
IRON has a Beta of 0.96 and 52-week volatility of 51%. It's less volatile than the S&P 500 - generally more stable.